Westlake BioPartners Opportunity Fund I, L.P. — Form D/A
Westlake BioPartners Opportunity Fund I, L.P. of WESTLAKE VILLAGE, CA, a pooled investment fund, filed a Form D amendment with the SEC on 2021-06-14. The offering totals $100.0M, of which $100.0M was reported sold. Industry: Pooled Investment Fund.
Offering
- Filed: 2021-06-14
- Form: D/A
- Accession: 0001811946-21-000001
- Industry: Pooled Investment Fund
- Exemptions: 06b, 3C, 3C.7
- Total offering: $100.0M
- Amount sold: $100.0M
- Investors: 25
- Date of first sale: 2020-07-07
- Security types: fund interests
- Revenue range: Not Applicable
- SEC file number: 021-370270
Issuer
- Name: Westlake BioPartners Opportunity Fund I, L.P.
- CIK: 0001811946
- Entity type: Limited Partnership
- Jurisdiction: DELAWARE
- Incorporated: 2020
- Address: 3075 TOWNSGATE ROAD, SUITE 140, WESTLAKE VILLAGE, CA, 91361
- Phone: 805-465-9588
Officers, directors & promoters (5)
| Name | Role | Location |
|---|
| Sean Harper | Director | Chicago, IL |
| Beth Seidenberg | Director | South San Francisco, CA |
| N/A Westlake BioPartners Opportunity GP I, LLC | Director | Westlake Village, CA |
| Peter Calveley | Executive Officer | Westlake Village, CA |
| Scott Ryles | Executive Officer | Westlake Village, CA |
Other filings by this issuer (1)
More